[1]
R. D. Puspitasari and I. L. Tarigan, “Molecular Docking and in Silico Pharmacokinetic Analysis of Peronemin As A Potential 17β-Hsd1 Inhibitor For Estrogen-Dependent Cancer Therapy”, HJKK, vol. 13, no. 6, pp. 1095–1103, Dec. 2025.